| 06th week of 2018 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20180036301 | LOCAL DELIVERY FORMS OF ACRIFLAVINE FOR TREATING TUMORS | 2018-02-08 |
| 20180036302 | TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND A STATIN | 2018-02-08 |
| 20180036303 | LSD FOR THE TREATMENT OF ALZHEIMER'S DISEASE | 2018-02-08 |
| 20180036304 | METHOD OF TREATING CANCER ASSOCIATED WITH A RAS MUTATION | 2018-02-08 |
| 20180036305 | Method of treating peripheral neuropathy | 2018-02-08 |
| 20180036306 | METHODS OF USE AND PHARMACEUTICAL COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS AND CD20 INHIBITORY ANTIBODIES | 2018-02-08 |
| 20180036307 | OXYMETHYLENE ARYL COMPOUNDS FOR TREATING INFLAMMATORY GASTROINTESTINAL DISEASES OR GASTROINTESTINAL CONDITIONS | 2018-02-08 |
| 20180036308 | NOVEL COMPOUNDS | 2018-02-08 |
| 20180036309 | SYNERGISTIC CANCER TREATMENT | 2018-02-08 |
| 20180036310 | INTRAVENOUS INFUSION DOSAGE FORM | 2018-02-08 |
| 20180036311 | TREATMENT FOR HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES (HNPP) | 2018-02-08 |
| 20180036312 | Novel Scaffolds for Intracellular Compound Delivery for the Detection of Cancer Cells | 2018-02-08 |
| 20180036313 | USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) | 2018-02-08 |
| 20180036314 | METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE | 2018-02-08 |
| 20180036315 | Oxazine Derivative for Use in the Prevention of Alzheimer's Disease in at Risk Patients | 2018-02-08 |
| 20180036316 | TREATMENT OF EPILEPTIC DISORDERS IN FELINE ANIMALS | 2018-02-08 |
| 20180036317 | METHOD OF TREATING CONDITIONS WITH KINASE INHIBITORS | 2018-02-08 |
| 20180036318 | METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISM AND PROST A TE CANCER | 2018-02-08 |
| 20180036319 | TRANSDERMAL DRUG DELIVERY SYSTEMS FOR NORETHINDRONE ACETATE | 2018-02-08 |
| 20180036320 | NOVEL C-17-HETEROARYL STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS, IN VITRO BIOLOGICAL ACTIVITIES, PHARMACOKINETICS AND ANTITUMOR ACTIVITY | 2018-02-08 |
| 20180036321 | TRIPTOLIDE PRODRUGS | 2018-02-08 |
| 20180036322 | METHODS AND MATERIALS FOR TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS | 2018-02-08 |
| 20180036323 | COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF GASTROINTESTINAL INFECTIONS/INFLAMMATIONS IN INFANTS OR YOUNG CHILDREN | 2018-02-08 |
| 20180036324 | COMPOSITION FOR PREVENTING OR TREATING LIVER CANCER CONTAINING GINSENOSIDE F2 | 2018-02-08 |
| 20180036325 | L-ARABINOSE PLUS CHROMIUM FOR CONTROLLING THE METABOLIZATION OF SUCROSE | 2018-02-08 |
| 20180036326 | METHOD FOR TREATING HIV | 2018-02-08 |
| 20180036327 | COMPOSITION AND METHOD FOR TREATING ACUTE RESPIRATORY TRACT INFECTIONS | 2018-02-08 |
| 20180036328 | METHOD OF IMPROVING LACRIMAL SECRETION FOR DRY EYE TREATMENT USING MACQUI BERRY EXTRACT | 2018-02-08 |
| 20180036329 | METHODS FOR TREATING OCULAR INFLAMMATORY DISORDERS | 2018-02-08 |
| 20180036330 | NUCLEOTIDE PHOSPHORAMIDATE FORMULATION | 2018-02-08 |
| 20180036331 | TREATMENT OF DRUG RESISTANT PROLIFERATIVE DISEASES WITH TELOMERASE MEDIATED TELOMERE ALTERING COMPOUNDS | 2018-02-08 |
| 20180036332 | USE OF NADPH IN PREPARING MEDICINES FOR TREATMENT OF HEART DISEASES | 2018-02-08 |
| 20180036333 | AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF | 2018-02-08 |
| 20180036334 | RNA CONTAINING COMPOSITIONS AND METHODS OF THEIR USE | 2018-02-08 |
| 20180036335 | COMPOSITIONS FOR MODULATING MECP2 EXPRESSION | 2018-02-08 |
| 20180036336 | COMBINATION TREATMENT FOR HEMATOLOGICAL CANCERS | 2018-02-08 |
| 20180036337 | TOPICAL COMPOSITION FOR THE TREATMENT OF MUCOSAL LESIONS | 2018-02-08 |
| 20180036338 | FLOWABLE HEMOSTATIC COMPOSITION | 2018-02-08 |
| 20180036339 | Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 | 2018-02-08 |
| 20180036340 | TOPICAL AND ORAL FORMULATIONS COMPRISING TAURINE AND MAGNESIUM FOR THE PREVENTION AND TREATMENT OF ACNE | 2018-02-08 |
| 20180036341 | METHOD OF USING CARBONIZED MATERIAL TO INHIBIT BACTERIA | 2018-02-08 |
| 20180036342 | INCREASING THE HALF-LIFE OF HYDROGEN PEROXIDE IN AN INGESTIBLE COMPOSITION | 2018-02-08 |
| 20180036343 | Pain Relief Salt Composition and Method | 2018-02-08 |
| 20180036344 | TARGETED TRANSPLANTATION OF MITOCHONDRIA TO HEPATOCYTES | 2018-02-08 |
| 20180036345 | EXPANSION OF ALLOANTIGEN-REACTIVE REGULATORY T CELLS | 2018-02-08 |
| 20180036346 | Cell Preparations For Extemporaneous Use, Useful For Healing And Rejuvenation In Vivo | 2018-02-08 |
| 20180036347 | PROLINE-RICH POLYPEPTIDE COMPLEX FOR USE IN TREATMENT OF BDNF-DEPENDENT DISORDERS | 2018-02-08 |
| 20180036348 | INTRATHECAL ADMINISTRATION OF MESENCHYMAL STEM CELLS AND DERIVATIVES THEREOF FOR TREATMENT OF PAIN | 2018-02-08 |
| 20180036349 | Treatment for Chronic Pain | 2018-02-08 |
| 20180036350 | HYALURONIC ACID PRODUCTION PROMOTING AGENT | 2018-02-08 |
| 20180036351 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | 2018-02-08 |
| 20180036352 | METHODS FOR TREATING ULCERATIVE COLITIS | 2018-02-08 |
| 20180036353 | TREATMENT OF RESPIRATORY TRACT ILLNESS WITH BIFIDOBACTERIUM LACTIS BL-04 | 2018-02-08 |
| 20180036354 | CVS TRANSPLANTATION FOR TREATMENT OF BACTERIAL VAGINOSIS | 2018-02-08 |
| 20180036355 | STRAIN OF LACTOBACILLUS ACIDOPHILUS HAVING ANALGESIC PROPERTIES IN THE GASTROINTESTINAL SYSTEM | 2018-02-08 |
| 20180036356 | METHOD FOR PREVENTING AND/OR TREATING INFECTIONS, COLONISATIONS, OR ILLNESSES RELATED TO STAPHYLOCOCCUS AUREUS, PSEUDOMONAS AERUGINOSA, STREPTOCOCCUS PYOGENES, ENTEROCOCCUS FAECIUM, ENTEROBACTER CLOACAE, PROTEUS MIRABILIS, BACTEROIDES FRAGILIS, STAPHYLOCOCCUS EPIDERMIDIS, PROPIONIBACTERIUM ACNES, CANDIDA ALBICANS AND/OR MALASSEZIA FURFUR | 2018-02-08 |
| 20180036357 | TRANSGENIC MICROALGAE AND USE THEREOF FOR ORAL DELIVERY OF PROTEINS | 2018-02-08 |
| 20180036358 | COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS | 2018-02-08 |
| 20180036359 | PROCESS TO OBTAIN A NUTRACEUTICAL FORMULATION OF AMARANTH AND ITS USE IN TREATING HUMAN BEHAVIOR DISORDERS | 2018-02-08 |
| 20180036360 | IMMUNOLOGICALLY ACTIVE PHYTO-MIXTURE AND ITS USE IN THE PREVENTION AND IN A METHOD FOR TREATMENT OF EFFLORESCENCES | 2018-02-08 |
| 20180036361 | COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN | 2018-02-08 |
| 20180036362 | TECAP Liquid | 2018-02-08 |
| 20180036363 | PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCT | 2018-02-08 |
| 20180036364 | METHODS OF TREATING CANCER WITH A PSMA LIGAND-TUBULYSIN COMPOUND | 2018-02-08 |
| 20180036365 | COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING NEUROLOGICAL DISEASE CONTAINING OSMOTIN PEPTIDE AS ACTIVE INGREDIENT | 2018-02-08 |
| 20180036366 | ADMINSTRATION OF RECOMBINANT COLLAGEN 7 FOR THE TREATMENT OF AGE RELATED DISORDERS | 2018-02-08 |
| 20180036367 | METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN | 2018-02-08 |
| 20180036368 | COMBINED VACCINATION/RADIOTERAPY FOR CANCER TREATMENT | 2018-02-08 |
| 20180036369 | COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS | 2018-02-08 |
| 20180036370 | USE OF HAPTOGLOBIN SUBUNIT FOR PROMOTING ANGIOGENESIS | 2018-02-08 |
| 20180036371 | DERMATOPONTIN AS A THERAPEUTIC FOR METABOLIC DISORDERS | 2018-02-08 |
| 20180036372 | TREATMENT AGENT FOR COGNITIVE IMPAIRMENT INDUCED BY AMYLOID BETA-PROTEIN, THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE, AND TREATMENT METHOD AND PATHOLOGICAL ANALYSIS METHOD RELATED TO THESE | 2018-02-08 |
| 20180036373 | USE OF HAPTOGLOBIN SUBUNIT FOR PROMOTING WOUND HEALING | 2018-02-08 |
| 20180036374 | Single Walled Carbon Nanotube Polynucleotide Complexes and Methods Related Thereto | 2018-02-08 |
| 20180036375 | Spatiotemporal Delivery Vehicle and Related Methods | 2018-02-08 |
| 20180036376 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | 2018-02-08 |
| 20180036377 | METHODS FOR TREATING METABOLIC DISORDERS USING FGF | 2018-02-08 |
| 20180036378 | METHODS AND COMPOSITIONS FOR STIMULATION OF CELL PROLIFERATION AND PROVISION OF BIOLOGICALLY ACTIVE MIXTURES OF FGF2 ISOFORMS | 2018-02-08 |
| 20180036379 | Method of Treating Psoriasis with Increased Interval Dosing of Anti-IL12/23 Antibody | 2018-02-08 |
| 20180036380 | TREATMENTS FOR MIGRAINE AND RELATED DISORDERS | 2018-02-08 |
| 20180036381 | THYMOSIN ALPHA 1 FOR USE IN TREATMENT OF CYSTIC FIBROSIS | 2018-02-08 |
| 20180036382 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE | 2018-02-08 |
| 20180036383 | TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL DEGENERATIVE DISORDER | 2018-02-08 |
| 20180036384 | PEPTIDE FOR PREVENTING HEARING LOSS, AND COMPOSITION COMPRISING SAME | 2018-02-08 |
| 20180036385 | AAV-MEDIATED GENE THERAPY FOR RPGR X-LINKED RETINAL DEGENERATION | 2018-02-08 |
| 20180036386 | METHODS AND COMPOSITIONS FOR INTRATHECALLY ADMINISTERED TREATMENT OF MUCUPOLYSACCHARIDOSIS TYPE IIIA | 2018-02-08 |
| 20180036387 | PROCESS FOR PRODUCTION AND PURIFICATION OF RECOMBINANT LYSOSOMAL ALPHA-MANNOSIDASE | 2018-02-08 |
| 20180036388 | ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM | 2018-02-08 |
| 20180036389 | DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY | 2018-02-08 |
| 20180036390 | TREATMENT OF ROSACEA WITH COMPOSITIONS CONTAINING BROMELAIN | 2018-02-08 |
| 20180036391 | TREATMENT OF DERMAL ITCH WITH COMPOSITIONS CONTAINING BROMELAIN | 2018-02-08 |
| 20180036392 | TREATMENT OF ECZMA WITH COMPOSITIONS CONTAINING BROMELAIN | 2018-02-08 |
| 20180036393 | ENZYME COMPOSITIONS WITH REDUCED VIRAL AND MICROBIAL CONTAMINATION | 2018-02-08 |
| 20180036394 | PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR | 2018-02-08 |
| 20180036395 | DOSAGE AND ADMINISTRATION OF MONOSPECIFIC AND BISPECIFIC ANTI-IGR-1R AND ANTI-ERBB3 ANTIBODIES | 2018-02-08 |
| 20180036396 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA | 2018-02-08 |
| 20180036397 | ANTI-TUMOR VACCINE DERIVED FROM NORMAL CELLS | 2018-02-08 |
| 20180036398 | FLAVIVIRUS REPLICONS | 2018-02-08 |
| 20180036399 | Molecular Antigen Array | 2018-02-08 |
| 20180036400 | DOUBLE ENGINEERED HIV-1 ENVELOPES | 2018-02-08 |
